Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases
- PMID: 35414791
- PMCID: PMC8990456
- DOI: 10.7150/ijbs.70955
Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases
Abstract
Protein homeostasis is well accepted as the prerequisite for proper operation of various life activities. As the main apparatus of protein translation, ribosomes play an indispensable role in the maintenance of protein homeostasis. Nevertheless, upon stimulation of various internal and external factors, malfunction of ribosomes may be evident with the excessive production of aberrant proteins, accumulation of which can result in deleterious effects on cellular fate and even cell death. Ribosomopathies are characterized as a series of diseases caused by abnormalities of ribosomal compositions and functions. Correspondingly, cell evolves several ribosome quality control mechanisms in maintaining the quantity and quality of intracellular ribosomes, namely ribosome quality control system (RQCS). Of note, RQCS can tightly monitor the entire process from ribosome biogenesis to its degradation, with the capacity of coping with ribosomal dysfunction, including misassembled ribosomes and incorrectly synthesized ribosomal proteins. In the current literature review, we mainly introduce the RQCS and elaborate on the underlying pathogenesis of several ribosomopathies. With the in-depth understanding of ribosomal dysfunction and molecular basis of RQCS, therapeutic strategy by specifically targeting RQCS remains a promising option in treating patients with ribosomopathies and other ribosome-associated human diseases.
Keywords: Human diseases; Ribophagy; Ribosome; Ribosome quality control; Ribosomopathy.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Eukaryotic ribosome biogenesis at a glance.J Cell Sci. 2013 Nov 1;126(Pt 21):4815-21. doi: 10.1242/jcs.111948. J Cell Sci. 2013. PMID: 24172536
-
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.Cancer Res. 2022 Jul 5;82(13):2344-2353. doi: 10.1158/0008-5472.CAN-21-4087. Cancer Res. 2022. PMID: 35303060 Free PMC article. Review.
-
Probing the mechanisms underlying human diseases in making ribosomes.Biochem Soc Trans. 2016 Aug 15;44(4):1035-44. doi: 10.1042/BST20160064. Biochem Soc Trans. 2016. PMID: 27528749 Free PMC article. Review.
-
Ribosomopathies: New Therapeutic Perspectives.Cells. 2020 Sep 11;9(9):2080. doi: 10.3390/cells9092080. Cells. 2020. PMID: 32932838 Free PMC article. Review.
-
Ribosomal heterogeneity - A new inroad for pharmacological innovation.Biochem Pharmacol. 2020 May;175:113874. doi: 10.1016/j.bcp.2020.113874. Epub 2020 Feb 24. Biochem Pharmacol. 2020. PMID: 32105657 Review.
Cited by
-
Co-Translational Quality Control Induced by Translational Arrest.Biomolecules. 2023 Feb 7;13(2):317. doi: 10.3390/biom13020317. Biomolecules. 2023. PMID: 36830686 Free PMC article. Review.
-
Comparative analysis and classification of highly divergent mouse rDNA units based on their intergenic spacer (IGS) variability.NAR Genom Bioinform. 2024 Jun 14;6(2):lqae070. doi: 10.1093/nargab/lqae070. eCollection 2024 Jun. NAR Genom Bioinform. 2024. PMID: 38881577 Free PMC article.
-
Nuclear fragile X mental retardation-interacting protein 1-mediated ribophagy protects T lymphocytes against apoptosis in sepsis.Burns Trauma. 2023 Feb 28;11:tkac055. doi: 10.1093/burnst/tkac055. eCollection 2023. Burns Trauma. 2023. PMID: 36873287 Free PMC article.
-
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.Elife. 2024 Apr 29;12:RP90683. doi: 10.7554/eLife.90683. Elife. 2024. PMID: 38682900 Free PMC article.
-
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.bioRxiv [Preprint]. 2024 Jan 10:2023.07.26.550648. doi: 10.1101/2023.07.26.550648. bioRxiv. 2024. Update in: Elife. 2024 Apr 29;12:RP90683. doi: 10.7554/eLife.90683. PMID: 37546802 Free PMC article. Updated. Preprint.
References
-
- Shao S, Hegde RS. Target selection during protein quality control. Trends Biochem Sci. 2016;41:124–37. - PubMed
-
- Choe YJ, Park SH, Hassemer T, Körner R, Vincenz-Donnelly L, Hayer-Hartl M. et al. Failure of RQC machinery causes protein aggregation and proteotoxic stress. Nature. 2016;531:191–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials